Notice of Funding Opportunity (NOFO) for Revision Applications to Accelerate the Translation of NCI-Supported Methods/Assays/Technologies to the Clinic
National Institutes of Health
Description
This grant opportunity invites applications aimed at adapting and clinically validating molecular, cellular, or imaging markers to improve cancer detection, diagnosis, prognosis, monitoring, and treatment response prediction, as well as cancer prevention and control. It supports obtaining well-documented specimens from NCI-supported or other clinical trials or observational cohorts for validating these assays. The grant encourages collaboration among scientists, assay developers, clinicians,…
The focus of applications submitted in response to this NOFO should be on the adaption and clinical validation of molecular/cellular/imaging markers for cancer detection, diagnosis, prognosis, monitoring, and prediction of response in treatment, as well as markers for cancer prevention and contr…
Source
Grant ID
PAR-24-304
Agency
National Institutes of Health
Subcategory/Subagency
National Cancer Institute
Key Dates
Opportunity Released
October 10, 2024
Open for Submission
October 10, 2024
Submission Deadline
October 14, 2026
Application Window Closes
October 14, 2026
Eligibility
The following categories of applicants are invited to apply:
- Higher Education Institutions - Public/State Controlled Institutions of Higher Education
- Higher Education Institutions - Private Institutions of Higher Education
- Nonprofits Other Than Institutions of Higher Education - Nonprofits with 501(c)(3) IRS Status
- Nonprofits Other Than Institutions of Higher Education - Nonprofits without 501(c)(3) IRS Status
- For-Profit Organizations - Small Businesses
- For-Profit Organizations (Other than Small Businesses)
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Local Governments (General/unspecified)
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Eligible Agencies of the Federal Government
- U.S. Territory or Possession
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Faith-based or Community-based Organizations
- Regional Organizations
- Non-domestic (non-U.S.) Entities (Foreign Organizations)
- Non-domestic (non-U.S.) components of U.S. Organizations
Similar opportunities
- Validation of Biomarkers for Cancer Detection, Diagnosis, and Treatment
National Institutes of Health
- NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
Department of Health and Human Services
- Exploratory Research Projects for Innovative Molecular Analysis Technologies in Cancer Research
National Institutes of Health
- Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
Department of Health and Human Services
- Facilitating Clinical Trials in Cancer Prevention and Control
National Institutes of Health